These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 15230126)
1. [Serum nitrates in patients with systemic lupus erythematosus and antiphospholipid syndrome]. Reshetniak DV; Kuznetsova TV; Kobylianskiĭ AG; Kliukvina NG; Reshetniak TM; Nasonov EL Ter Arkh; 2004; 76(5):19-22. PubMed ID: 15230126 [TBL] [Abstract][Full Text] [Related]
2. [Soluble adhesion molecules in antiphospholipid syndrome associated with systemic lupus erythematosus and in primary antiphospholipid syndrome]. Aleksandrova EN; Novikov AA; Reshetniak TM; Kliukvina NG; Reshetniak DV; Samsonov MIu; Nasonov EL Ter Arkh; 2002; 74(5):23-7. PubMed ID: 12087900 [TBL] [Abstract][Full Text] [Related]
3. [The role of hyperhomocysteinemia in systemic lupus erythematosus and antiphospholipid syndrome]. Reshetniak TM; Shirokova IE; Lisitskaia TL Ter Arkh; 2006; 78(6):24-30. PubMed ID: 16881359 [TBL] [Abstract][Full Text] [Related]
4. Primary antiphospholipid syndrome as the forerunner of systemic lupus erythematosus. Tarr T; Lakos G; Bhattoa HP; Szegedi G; Shoenfeld Y; Kiss E Lupus; 2007; 16(5):324-8. PubMed ID: 17576733 [TBL] [Abstract][Full Text] [Related]
6. [Subclinical and clinical manifestations of atherosclerosis in antiphospholipid syndrome]. Reshetniak TM; Seredavkina nV; Mach ES; Aleksandrova EN; Novikov AA; Cherkasova MV; Nasonov EL Ter Arkh; 2008; 80(10):60-7. PubMed ID: 19105418 [TBL] [Abstract][Full Text] [Related]
7. Classification of an intermediate group of patients with antiphospholipid syndrome and lupus-like disease: primary or secondary antiphospholipid syndrome? Weber M; Hayem G; De Bandt M; Seifert B; Palazzo E; Roux S; Kahn MF; Meyer O J Rheumatol; 1999 Oct; 26(10):2131-6. PubMed ID: 10529128 [TBL] [Abstract][Full Text] [Related]
8. [Antibodies to beta2-glycoprotein I and antibodies to cardiolipin in antiphospholipid syndrome: analysis of sensitivity and specificity]. Aleksandrova EN; Novikov AA; Reshetniak TM; Kliukvina HG; Reshetniak DV; Nasonov EL Klin Med (Mosk); 2003; 81(9):25-31. PubMed ID: 14598587 [TBL] [Abstract][Full Text] [Related]
9. [Osteonecroses in systemic lupus erythematosus and antiphospholipid syndrome]. Reshetniak TM; Lisitsyna TA; Nasonov EL Klin Med (Mosk); 2004; 82(6):46-51. PubMed ID: 15344691 [TBL] [Abstract][Full Text] [Related]
10. [Antiphospholipid syndrome and exogenic risk factors in thromboses]. Tikhonova TL; Mach ES; Shirokova IE; Reshetniak TM Ter Arkh; 2004; 76(11):71-4. PubMed ID: 15658543 [TBL] [Abstract][Full Text] [Related]
14. Serum inhibin A levels in pregnant women with systemic lupus erythematosus or antiphospholipid syndrome. Maymon R; Sehmi IK; Herman A; Jones RG; Sherman D; Cuckle H Prenat Diagn; 2000 Jan; 20(1):12-6. PubMed ID: 10701844 [TBL] [Abstract][Full Text] [Related]
15. Serum levels of vascular endothelial growth factor in children and adolescents with systemic lupus erythematosus. Heshmat NM; El-Kerdany TH Pediatr Allergy Immunol; 2007 Jun; 18(4):346-53. PubMed ID: 17346298 [TBL] [Abstract][Full Text] [Related]
16. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus. Danowski A; de Azevedo MN; de Souza Papi JA; Petri M J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935 [TBL] [Abstract][Full Text] [Related]
17. High impact of antiphospholipid syndrome on irreversible organ damage and survival of patients with systemic lupus erythematosus. Ruiz-Irastorza G; Egurbide MV; Ugalde J; Aguirre C Arch Intern Med; 2004 Jan; 164(1):77-82. PubMed ID: 14718326 [TBL] [Abstract][Full Text] [Related]